Tag: anti-pd-l1 antibody

Tenofovir disoprovil fumarate HIV prophylaxis linked with minimal kidney impact

Atezolizumab does not reduce post-resection recurrence in patients with renal cell carcinoma

byNeel Mistryand1 others

October 11, 2022

1. Atezolizumab was associated with non-significantly increased disease-free survival compared to placebo (57.2 months vs. 49.5 months). 2. Serious adverse ...

#VisualAbstract: Pembrolizumab improves long-term survival in patients with stage III melanoma

#VisualAbstract: Avelumab does not improve outcomes in patients receiving chemoradiotherapy for squamous cell carcinomas of the head and neck

byTeddy Guo

May 6, 2021

Click to read the study in The Lancet Oncology.

Dacomitinib may be effective in EGFR-associated lung cancer

Cemiplimab monotherapy significantly improves outcomes in patients with advanced non-small-cell lung cancer with PD-L1 of at least 50%

byNeel Mistryand1 others

June 25, 2021

1. Median overall survival and progression-free survival were significantly improved with cemiplimab monotherapy compared to chemotherapy. 2. Patients treated with ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result